CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionAptus Capital Advisors, LLC
Latest Disclosed Ownership7,662 shares
Latest Disclosed Value $ 2,262,972
Aptus Capital Advisors, LLC reports 4.39% decrease in ownership of MX4A / CME Group Inc.

On May 11, 2026 - Aptus Capital Advisors, LLC filed a 13F-HR form disclosing ownership of 7,662 shares of CME Group Inc. (DE:MX4A) valued at $1,957,258 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 8,014 shares of CME Group Inc.. This represents a change in shares of -4.39% during the quarter. The current value of the position is $1,668,784 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CME GROUP COM 12572Q105 7,662 -352 -4.39 2,263 3.38 0.0178
2026-02-13 2025-12-31 13F CME GROUP COM 12572Q105 8,014 -340 -4.07 2,188 -3.06 0.0157
2025-11-12 2025-09-30 13F CME GROUP COM 12572Q105 8,354 1,313 18.65 2,257 16.34 0.0164
2025-08-11 2025-06-30 13F CME GROUP COM 12572Q105 7,041 1,466 26.30 1,941 31.17 0.0158
2025-05-13 2025-03-31 13F CME GROUP COM 12572Q105 5,575 358 6.86 1,479 21.03 0.0152
2025-02-14 2024-12-31 13F CME GROUP COM 12572Q105 5,217 2,210 73.50 1,223 84.31 0.0128
2024-11-05 2024-09-30 13F CME GROUP COM 12572Q105 3,007 121 4.19 663 16.93 0.0099
2024-07-31 2024-06-30 13F CME GROUP COM 12572Q105 2,886 147 5.37 567 -3.74 0.0100
2024-05-15 2024-03-31 13F CME GROUP COM 12572Q105 2,739 425 18.37 590 20.94 0.0110
2024-02-13 2023-12-31 13F CME GROUP COM 12572Q105 2,314 25 1.09 487 6.33 0.0133
2023-11-08 2023-09-30 13F CME GROUP COM 12572Q105 2,289 911 66.11 458 79.61 0.0125
2023-08-11 2023-06-30 13F CME GROUP COM 12572Q105 1,378 135 10.86 255 7.14 0.0061
2023-05-09 2023-03-31 13F CME GROUP COM 12572Q105 1,243 1,243 238 0.0064
2023-02-13 2022-12-31 13F CME GROUP COM 12572Q105 0 -22,885 -100.00 0 -100.00
2022-11-02 2022-09-30 13F CME GROUP COM 12572Q105 22,885 22,885 4,054 0.0976
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.